Eli Lilly and Company
US ˙ NYSE ˙ US5324571083

SecurityLLY / Eli Lilly and Company
InstitutionCNB Bank
Latest Disclosed Ownership1,619 shares
Latest Disclosed Value $ 1,489,108
CNB Bank reports 11.42% increase in ownership of LLY / Eli Lilly and Company

On May 6, 2026 - CNB Bank filed a 13F-HR form disclosing ownership of 1,619 shares of Eli Lilly and Company (US:LLY) valued at $1,489,108 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 1,453 shares of Eli Lilly and Company. This represents a change in shares of 11.42% during the quarter. The current value of the position is $1,746,545 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ELI LILLY COM 532457108 1,619 166 11.42 1,489 -4.61 0.6265
2026-02-11 2025-12-31 13F ELI LILLY COM 532457108 1,453 323 28.58 1,562 81.09 0.6390
2025-10-30 2025-09-30 13F ELI LILLY COM 532457108 1,130 -62 -5.20 862 -7.21 0.3592
2025-07-31 2025-06-30 13F ELI LILLY COM 532457108 1,192 -74 -5.85 929 -11.10 0.4405
2025-04-24 2025-03-31 13F ELI LILLY COM 532457108 1,266 11 0.88 1,046 7.95 0.5293
2025-01-15 2024-12-31 13F Eli Lilly COM 532457108 1,255 115 10.09 969 -4.06 0.4502
2024-10-18 2024-09-30 13F Eli Lilly COM 532457108 1,140 -29 -2.48 1,010 -4.63 0.4671
2024-08-08 2024-06-30 13F Eli Lilly COM 532457108 1,169 70 6.37 1,058 23.89 0.5091
2024-05-02 2024-03-31 13F Eli Lilly COM 532457108 1,099 123 12.60 855 50.35 0.4169
2024-01-31 2023-12-31 13F Eli Lilly COM 532457108 976 681 230.85 569 259.49 0.3055
2023-11-02 2023-09-30 13F Eli Lilly COM 532457108 295 -290 -49.57 158 -42.34 0.0933
2023-08-08 2023-06-30 13F Eli Lilly COM 532457108 585 -131 -18.30 274 11.84 0.1614
2023-05-10 2023-03-31 13F Eli Lilly COM 532457108 716 131 22.39 246 14.49 0.1497
2023-02-13 2022-12-31 13F Eli Lilly COM 532457108 585 0 0.00 214 13.23 0.1338
2022-11-14 2022-09-30 13F Eli Lilly COM 532457108 585 0 0.00 189 -0.53 0.1279
2022-08-19 2022-06-30 13F/A-1 Eli Lilly COM 532457108 585 0 0.00 190 13.10 0.1229
2022-08-10 2022-06-30 13F Eli Lilly COM 532457108 830 245 269 0.1109
2022-04-13 2022-03-31 13F Eli Lilly and COM 532457108 585 0 0.00 168 3.70 0.0931
2022-01-31 2021-12-31 13F Eli Lilly and COM 532457108 585 0 0.00 162 20.00 0.0888
2021-11-02 2021-09-30 13F Eli Lilly and COM 532457108 585 0 0.00 135 0.75 0.0811
2021-07-29 2021-06-30 13F Eli Lilly and COM 532457108 585 300 105.26 134 152.83 0.0838
2021-05-03 2021-03-31 13F Eli Lilly and COM 532457108 285 0 0.00 53 10.42 0.0367
2021-01-27 2020-12-31 13F Eli Lilly and COM 532457108 285 0 0.00 48 17.07 0.0363
2020-10-26 2020-09-30 13F Eli Lilly and COM 532457108 285 0 0.00 41 -12.77 0.0345
2020-07-14 2020-06-30 13F Eli Lilly and COM 532457108 285 0 0.00 47 17.50 0.0414
2020-05-13 2020-03-31 13F Eli Lilly and COM 532457108 285 -123 -30.15 40 -25.93 0.0431
2020-01-27 2019-12-31 13F Eli Lilly and COM 532457108 408 0 0.00 54 17.39 0.0457
2019-11-04 2019-09-30 13F Eli Lilly and COM 532457108 408 0 0.00 46 2.22 0.0426
2019-08-14 2019-06-30 13F Eli Lilly and COM 532457108 408 123 43.16 45 21.62 0.0384
2019-04-29 2019-03-31 13F Eli Lilly and COM 532457108 285 60 26.67 37 42.31 0.0191
2019-02-06 2018-12-31 13F Lilly Eli & Co Com COM 532457108 225 0 0.00 26 8.33 0.0166
2018-11-13 2018-09-30 13F Lilly Eli & Co Com COM 532457108 225 0 0.00 24 26.32 0.0137
2018-08-14 2018-06-30 13F Lilly Eli & Co Com COM 532457108 225 0 0.00 19 11.76 0.0111
2018-05-11 2018-03-31 13F Lilly Eli & Co Com COM 532457108 225 0 0.00 17 -10.53 0.0099
2018-02-20 2017-12-31 13F Lilly Eli & Co Com COM 532457108 225 225 19 0.0114
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.